Publicacións nas que colabora con Carmelo Aguirre Gómez (10)

2022

  1. Synergism interaction between genetic polymorphisms in drug metabolizing enzymes and NSAIDs on upper gastrointestinal haemorrhage: a multicenter case-control study

    Annals of medicine, Vol. 54, Núm. 1, pp. 379-392

2021

  1. A multicenter case–control study of the effect of e-nos VNTR polymorphism on upper gastrointestinal hemorrhage in NSAID users

    Scientific Reports, Vol. 11, Núm. 1

2020

  1. Corrigendum: Influence of Polymorphisms Involved in Platelet Activation and Inflammatory Response on Aspirin-Related Upper Gastrointestinal Bleeding: A Case-Control Study (Frontiers in Pharmacology, (2020), 11, 10.3389/fphar.2020.00860)

    Frontiers in Pharmacology

  2. Polymorphisms Involved in Platelet Activation and Inflammatory Response on Aspirin-Related Upper Gastrointestinal Bleeding: A Case-Control Study

    Frontiers in Pharmacology, Vol. 11

2018

  1. Only full adherence to proton pump inhibitors protects against drug-induced upper gastrointestinal bleeding

    European Journal of Clinical Pharmacology, Vol. 74, Núm. 11, pp. 1503-1511

2016

  1. CYP2C9 variants as a risk modifier of NSAID-related gastrointestinal bleeding: A case-control study

    Pharmacogenetics and Genomics, Vol. 26, Núm. 2, pp. 66-73

2011

  1. Selective serotonin reuptake inhibitors and gastrointestinal bleeding: A case-control study

    PLoS ONE, Vol. 6, Núm. 5

  2. Synergism between prior Anisakis simplex infections and intake of NSAIDs, on the risk of upper digestive bleeding: A case-control study

    PLoS Neglected Tropical Diseases, Vol. 5, Núm. 6

2010

  1. Erratum: Prevalence of CYP2C9 polymorphisms in the south of Europe (Pharmacogenomics Journal (2009) DOI: 10.1038/tpj.2009.16))

    Pharmacogenomics Journal

2009

  1. Prevalence of CYP2C9 polymorphisms in the south of Europe

    Pharmacogenomics Journal, Vol. 9, Núm. 5, pp. 306-310